Your browser doesn't support javascript.
loading
Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial.
Haverkos, Bradley; Zain, Jasmine; Kamdar, Manali; Neuwelt, Alexander; Davila, Eduardo; Bradeen, Xander; Major, Ajay; Bair, Steven; Jasem, Jagar; Smith, Clayton; Abbott, Diana; Porcu, Pierluigi.
Afiliação
  • Haverkos B; Division of Hematology, University of Colorado, Aurora, CO.
  • Zain J; Division of Hematology, City of Hope, Duarte, CA.
  • Kamdar M; Division of Hematology, University of Colorado, Aurora, CO.
  • Neuwelt A; Division of Hematology and Oncology, Virginia Commonwealth University, Richmond, VA.
  • Davila E; Division of Oncology, University of Colorado, Aurora, CO.
  • Bradeen X; Division of Hematology, University of Colorado, Aurora, CO.
  • Major A; Division of Hematology, University of Colorado, Aurora, CO.
  • Bair S; Division of Hematology, University of Colorado, Aurora, CO.
  • Jasem J; Division of Hematology, University of Colorado, Aurora, CO.
  • Smith C; Division of Hematology, University of Colorado, Aurora, CO.
  • Abbott D; Division of Hematology, University of Colorado, Aurora, CO.
  • Porcu P; Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA.
Blood Adv ; 8(3): 708-711, 2024 02 13.
Article em En | MEDLINE | ID: mdl-38150586
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / Nivolumabe Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células T Periférico / Nivolumabe Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2024 Tipo de documento: Article